Shares of Sandoz Group AG (OTCMKTS:SDZNY – Get Free Report) dropped 1% during mid-day trading on Friday . The stock traded as low as $44.46 and last traded at $44.62. Approximately 23,381 shares changed hands during mid-day trading, a decline of 31% from the average daily volume of 33,707 shares. The stock had previously closed at $45.06.
Analyst Upgrades and Downgrades
Separately, BNP Paribas lowered Sandoz Group from a “strong-buy” rating to a “hold” rating in a report on Monday, December 2nd.
Check Out Our Latest Stock Report on SDZNY
Sandoz Group Stock Down 1.0 %
Sandoz Group Company Profile
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Recommended Stories
- Five stocks we like better than Sandoz Group
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- What Are Treasury Bonds?
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- What is a Death Cross in Stocks?
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
